Patent intelligence · US
US 10052371
Compositions and methods for treatment of cancer using bacteria
Compositions and methods for treatment of cancer using bacteria
Patent details — US 10052371
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 21, 2018
- Expiration
- Aug 16, 2038
- Applicant
- Decoy Biosystems, Inc.
- Claims
- 12
- CPC classes
- A61K, A61K2039/521, A61K2039/522, A61K2039/523
Quick answer
US 10052371 (Compositions and methods for treatment of cancer using bacteria) is held by Decoy Biosystems, Inc.. Status: granted. Granted Aug 21, 2018. Expires Aug 16, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Decoy Biosystems, Inc.
- Grant date
- Expiration
- Claims
- 12
- CPC classes
- A61K, A61K2039/521, A61K2039/522, A61K2039/523, A61K2039/585, A61K31/11
More from Decoy Biosystems, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12226474
Methods and compositions for treating infections
granted -
US 11147844
Methods of treatment of infections using bacteria
granted -
US 11045504
Compositions and methods for treatment of cancer using bacteria
granted -
US 10195259
Compositions and methods for treatment of cancer using bacteria
granted -
US 9265804
Compositions and methods for treatment of cancer using bacteria
granted
Frequently asked questions
What is US patent 10052371?
US 10052371 (Compositions and methods for treatment of cancer using bacteria) is held by Decoy Biosystems, Inc.. Status: granted. Granted Aug 21, 2018. Expires Aug 16, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10052371?
Decoy Biosystems, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 6 pharmaceutical patents for this assignee.
When does US 10052371 expire?
Our index shows an expiration date of Aug 16, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.